Kalaris Therapeutics (KLRS) Equity Average (2019 - 2020)
Kalaris Therapeutics (KLRS) has 2 years of Equity Average data on record, last reported at $151.3 million in Q3 2020.
Kalaris Therapeutics (KLRS) has 2 years of Equity Average data on record, last reported at $151.3 million in Q3 2020.